Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide

American Journal of Ophthalmology

Volumn 155, Issue 6, 2013, Pages

  Kunikata, Hiroshi ^a   Yasuda, Masayuki ^a   Aizawa, Naoko ^a   Tanaka, Yuji ^a   Abe, Toshiaki ^a   Nakazawa, Toru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERVENTION STUDY; MALE; PHOTORECEPTOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA LUTEA; RETINAL VASCULAR DISEASE; TREATMENT OUTCOME; VITRECTOMY;

EID: 84877767687     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.01.013     Document Type: Article

References (36)

1. H. Kunikata, T. Abe, and K. Nishida Successful outcomes of 25- and 23-gauge vitrectomies for giant retinal tear detachments Ophthalmic Surg Lasers Imaging 42 6 2011 487 492
2. H. Kunikata, and K. Nishida Visual outcome and complications of 25-gauge vitrectomy for rhegmatogenous retinal detachment; 84 consecutive cases Eye (Lond) 24 6 2010 1071 1077
3. S. Kobayashi, S. Sato, and M. Inoue Comparison of 20- and 25-gauge vitrectomy for primary repair of rhegmatogenous retinal detachment Ophthalmic Surg Lasers Imaging 41 5 2010 550 554
4. G. Carifi Outcomes and complications of rhegmatogenous retinal detachment repair with selective sutureless 25-gauge pars plana vitrectomy Am J Ophthalmol 150 5 2010 757 758 author reply 758
5. D.H. Bourla, E. Bor, R. Axer-Siegel, K. Mimouni, and D. Weinberger Outcomes and complications of rhegmatogenous retinal detachment repair with selective sutureless 25-gauge pars plana vitrectomy Am J Ophthalmol 149 4 2010 630 634.e1
6. M.A. Von Fricken, N. Kunjukunju, C. Weber, and G. Ko 25-Gauge sutureless vitrectomy versus 20-gauge vitrectomy for the repair of primary rhegmatogenous retinal detachment Retina 29 4 2009 444 450
7. M. Mura, S.H. Tan, and M.D. De Smet Use of 25-gauge vitrectomy in the management of primary rhegmatogenous retinal detachment Retina 29 9 2009 1299 1304
8. D.M. Miller, C.D. Riemann, R.E. Foster, and M.R. Petersen Primary repair of retinal detachment with 25-gauge pars plana vitrectomy Retina 28 7 2008 931 936
9. M.M. Lai, A.J. Ruby, and R. Sarrafizadeh Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy Retina 28 5 2008 729 734
10. N. Acar, Z. Kapran, T. Altan, Y.B. Unver, S. Yurtsever, and Y. Kucuksumer Primary 25-gauge sutureless vitrectomy with oblique sclerotomies in pseudophakic retinal detachment Retina 28 8 2008 1068 1074
11. T. Wakabayashi, Y. Oshima, and H. Fujimoto Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography Ophthalmology 116 3 2009 519 528
12. C. Capeans, M.V. De Rojas, S. Lojo, and M.S. Salorio C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy Retina 18 6 1998 546 550
13. A.M. Abu el-Asrar, J. Van Damme, and W. Put Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders Am J Ophthalmol 123 5 1997 599 606
14. T. Nakazawa, M. Kayama, and M. Ryu Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment Invest Ophthalmol Vis Sci 52 3 2011 1384 1391
15. T. Nakazawa, T. Hisatomi, and C. Nakazawa Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis Proc Natl Acad Sci U S A 104 7 2007 2425 2430
16. T. Nakazawa, A. Matsubara, and K. Noda Characterization of cytokine responses to retinal detachment in rats Mol Vis 12 2006 867 878
17. M. Soheilian, K.H. Garfami, A. Ramezani, M. Yaseri, and G.A. Peyman Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema Retina 32 2 2012 314 321
18. H. Noma, H. Funatsu, T. Mimura, and K. Shimada Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion Retina 32 9 2012 1844 1852
19. M. Shimura, K. Yasuda, and T. Nakazawa Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema Retina 31 4 2011 748 754
20. J.H. Bae, C.S. Lee, and S.C. Lee Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema Retina 31 1 2011 111 118
21. H. Ahmadieh, R. Taei, and M. Riazi-Esfahani Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial Retina 31 9 2011 1819 1826
22. C.S. Bergstrom, and G.B. Hubbard 3rd Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease Retina 28 3 Suppl 2008 S33 S37
23. C.H. Park, G.J. Jaffe, and S. Fekrat Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion Am J Ophthalmol 136 3 2003 419 425
24. A. Martidis, J.S. Duker, and P.B. Greenberg Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 5 2002 920 927
25. R.J. Antcliff, D.J. Spalton, M.R. Stanford, E.M. Graham, T.J. ffytche, and J. Marshall Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study Ophthalmology 108 4 2001 765 772
26. R. Rasier, U. Gormus, O. Artunay, E. Yuzbasioglu, M. Oncel, and H. Bahcecioglu Vitreous levels of VEGF, IL-8, and TNF-alpha in retinal detachment Curr Eye Res 35 6 2010 505 509
27. T. Yoshimura, K.H. Sonoda, and M. Sugahara Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases PLoS One 4 12 2009 e8158
28. Y. Mitamura, S. Takeuchi, and S. Yamamoto Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy Jpn J Ophthalmol 46 2 2002 218 221
29. Y. Tano, D. Chandler, and R. Machemer Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide Am J Ophthalmol 90 6 1980 810 816
30. D. Mitry, M.A. Awan, and S. Borooah Long-term visual acuity and the duration of macular detachment: findings from a prospective population-based study Br J Ophthalmol 97 2 2013 149 152
31. R. Ehrlich, R.L. Niederer, N. Ahmad, and P. Polkinghorne Timing of acute macula-on rhegmatogenous retinal detachment repair Retina 33 1 2013 105 110
32. K. Ishikawa, S. Yoshida, and S. Nakao Bone marrow-derived monocyte lineage cells recruited by MIP-1beta promote physiological revascularization in mouse model of oxygen-induced retinopathy Lab Invest 92 1 2012 91 101
33. K. Ishikawa, S. Yoshida, and K. Kadota Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy Invest Ophthalmol Vis Sci 51 8 2010 4307 4319
34. H. Kunikata, M. Shimura, and T. Nakazawa Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion Acta Ophthalmol 90 2 2010 162 167
35. A.M. Abu El-Asrar, S. Struyf, D. Kangave, K. Geboes, and J. Van Damme Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy Eur Cytokine Netw 17 3 2006 155 165
36. T.T. Woo, S.Y. Li, W.W. Lai, D. Wong, and A.C. Lo Neuroprotective effects of lutein in a rat model of retinal detachment Graefes Arch Clin Exp Ophthalmol 251 1 2013 41 51